Mucosa-attached bacterial community in Crohn’s disease coheres with the clinical disease activity index

Environmental Microbiology Reports

Volumn 8, Issue 5, 2016, Pages 614-621

  Schäffler, Holger ^a   Herlemann, Daniel P R ^b   Alberts, Christian ^a   Kaschitzki, Annika ^a   Bodammer, Peggy ^a   Bannert, Karen ^a   Köller, Thomas ^c   Warnke, Philipp ^c   Kreikemeyer, Bernd ^c   Lamprecht, Georg ^a  

^a UNIVERSITY MEDICAL CENTER ROSTOCK   (Germany)

^b LEIBNIZ INSTITUTE FOR BALTIC SEA RESEARCH   (Germany)

^c ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007473239     PISSN: None     EISSN: 17582229     Source Type: Journal    
DOI: 10.1111/1758-2229.12411     Document Type: Article

References (50)

1. Abraham, C., and Cho, J.H. (2009) Inflammatory bowel disease. N Engl J Med 361: 2066-2078.
2. Andoh, A., Imaeda, H., Aomatsu, T., Inatomi, O., Bamba, S., Sasaki, M., et al. (2011) Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn’s disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol 46: 479-486.
3. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., et al. (2011) Enterotypes of the human gut microbiome. Nature 473: 174-180.
4. Backhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., and Gordon, J.I. (2005) Host-bacterial mutualism in the human intestine. Science 307: 1915-1920.
5. Baumgart, D.C. (2009) The diagnosis and treatment of Crohn’s disease and ulcerative colitis. Dtsch Arztebl Int 106: 123-133.
6. Best, W.R., Becktel, J.M., Singleton, J.W., and Kern, F., Jr (1976) Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70: 439-444.
7. Caporaso, J.G., Lauber, C.L., Walters, W.A., Berg-Lyons, D., Lozupone, C.A., Turnbaugh, P.J., et al. (2011) Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci USA 108 (Suppl 1): 4516-4522.
8. Chassaing, B., and Darfeuille-Michaud, A. (2011) The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140: 1720-1728.
9. Cosnes, J., Gower-Rousseau, C., Seksik, P., and Cortot, A. (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140: 1785-1794.
10. Couturier-Maillard, A., Secher, T., Rehman, A., Normand, S., De Arcangelis, A., Haesler, R., et al. (2013) NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 123: 700-711.
11. Darfeuille-Michaud, A., Neut, C., Barnich, N., Lederman, E., Di Martino, P., Desreumaux, P., et al. (1998) Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease. Gastroenterology 115: 1405-1413.
12. Dicksved, J., Halfvarson, J., Rosenquist, M., Jarnerot, G., Tysk, C., Apajalahti, J., et al. (2008) Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. ISME J 2: 716-727.
13. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
14. Favier, C., Neut, C., Mizon, C., Cortot, A., Colombel, J.F., and Mizon, J. (1997) Fecal beta-d-galactosidase production and Bifidobacteria are decreased in Crohn’s disease. Dig Dis Sci 42: 817-822.
15. Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N., and Pace, N.R. (2007) Molecularphylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104: 13780-13785.
16. Frank, D.N., Zhu, W., Sartor, R.B., and Li, E. (2011) Investigating the biological and clinical significance of human dysbioses. Trends Microbiol 19: 427-434.
17. Hammer, Ø., Harper, D.A.T., Ryan, P.D. (2001) PAST: paleontological statistics software package for education and data analysis. Palaeontol Electron 4: 9 pp.
18. Hampe, J., Cuthbert, A., Croucher, P.J., Mirza, M.M., Mascheretti, S., Fisher, S., et al. (2001) Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 357: 1925-1928.
19. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411: 599-603.
20. Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., et al. (2014) A decrease of the butyrateproducing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63: 1275-1283.
21. Machiels, K., Sabino, J., Vandermosten, L., Joossens, M., Arijs, I., de Bruyn, M., et al. (2015) Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Gut.
22. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., et al. (2006) Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 55: 205-211.
23. Manichanh, C., Borruel, N., Casellas, F., and Guarner, F. (2012) The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9: 599-608.
24. Martinez-Medina, M., and Garcia-Gil, L.J. (2014) Escherichia coli in chronic inflammatory bowel diseases: an update on adherent invasive Escherichia coli pathogenicity. World J Gastrointest Pathophysiol 5: 213-227.
25. Momozawa, Y., Deffontaine, V., Louis, E., and Medrano, J.F. (2011) Characterization of bacteria in biopsies of colon and stools by high throughput sequencing of the V2 region of bacterial 16S rRNA gene in human. PLoS One 6: e16952.
26. Neish, A.S. (2009) Microbes in gastrointestinal health and disease. Gastroenterology 136: 65-80.
27. Nishikawa, J., Kudo, T., Sakata, S., Benno, Y., and Sugiyama, T. (2009) Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. Scand J Gastroenterol 44: 180-186.
28. Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411: 603-606.
29. Ott, S.J., Musfeldt, M., Wenderoth, D.F., Hampe, J., Brant, O., Folsch, U.R., et al. (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53: 685-693.
30. Petnicki-Ocwieja, T., Hrncir, T., Liu, Y.J., Biswas, A., Hudcovic, T., Tlaskalova-Hogenova, H., and Kobayashi, K.S. (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA 106: 15813-15818.
31. Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., et al. (2013) The SILVA ribosomal RNA gene database project: improved data processing and webbased tools. Nucleic Acids Res 41: D590-D596.
32. Rajca, S., Grondin, V., Louis, E., Vernier-Massouille, G., Grimaud, J.C., Bouhnik, Y., et al. (2014) Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn’s disease. Inflamm Bowel Dis 20: 978-986.
33. Rehman, A., Sina, C., Gavrilova, O., Hasler, R., Ott, S., Baines, J.F., et al. (2011) NOD2 is essential for temporal development of intestinal microbial communities. Gut 60: 1354-1362.
34. Robertson, C.E., Harris, J.K., Wagner, B.D., Granger, D., Browne, K., Tatem, B., et al. (2013) Explicet: graphical user interface software for metadata-driven management, analysis and visualization of microbiome data. Bioinformatics 29: 3100-3101.
35. Sartor, R.B. (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594.
36. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., and Huttenhower, C. (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12: R60.
37. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, Y.M., et al. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341: 569-573.
38. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L.G., Gratadoux, J.J., et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105: 16731-16736.
39. Sokol, H., Seksik, P., Furet, J.P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., et al. (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15: 1183-1189.
40. Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V., Ortner, M., et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
41. Swidsinski, A., Loening-Baucke, V., Vaneechoutte, M., and Doerffel, Y. (2008) Active Crohn’s disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 14: 147-161.
42. Tong, M., Li, X., Wegener Parfrey, L., Roth, B., Ippoliti, A., Wei, B., et al. (2013) A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One 8: e80702.
43. Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., et al. (2014) Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrateproducing bacteria in inflammatory bowel disease. J Clin Microbiol 52: 398-406.
44. Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schaffeler, E., Schlee, M., et al. (2004) NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal alpha-defensin expression. Gut 53: 1658-1664.
45. Wehkamp, J., Salzman, N.H., Porter, E., Nuding, S., Weichenthal, M., Petras, R.E., et al. (2005) Reduced Paneth cell alpha-defensins in ileal Crohn’s disease. Proc Natl Acad Sci USA 102: 18129-18134.
46. Willing, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Jarnerot, G., Engstrand, L., et al. (2009) Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn’s disease. Inflamm Bowel Dis 15: 653-660.
47. Willing, B.P., Dicksved, J., Halfvarson, J., Andersson, A.F., Lucio, M., Zheng, Z., et al. (2010) A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139: 1844-1854 e1.
48. Wills, E.S., Jonkers, D.M., Savelkoul, P.H., Masclee, A.A., Pierik, M.J., and Penders, J. (2014) Fecal microbial composition of ulcerative colitis and Crohn’s disease patients in remission and subsequent exacerbation. PLoS One 9: e90981.
49. Wu, G.D., Lewis, J.D., Hoffmann, C., Chen, Y.Y., Knight, R., Bittinger, K., et al. (2010) Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol 10: 206.
50. Zasloff, M. (2002) Antimicrobial peptides in health and disease. N Engl J Med 347: 1199-1200.